BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29268438)

  • 1. Prof. Boris Sepesi: patient-personalized treatment is the best treatment.
    Jia Z; Wu S; Zhong J
    J Thorac Dis; 2017 Oct; 9(10):E925-E927. PubMed ID: 29268438
    [No Abstract]   [Full Text] [Related]  

  • 2. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In memoriam Prof. Boris Samoilovich Sigal].
    Sov Zdravookhr; 1959; 18(5):52-3. PubMed ID: 13659222
    [No Abstract]   [Full Text] [Related]  

  • 4. [In memoriam Prof. Boris Moiseevich Mlechin].
    Vestn Otorinolaringol; 1980; (2):89-90. PubMed ID: 6446190
    [No Abstract]   [Full Text] [Related]  

  • 5. [60th Anniversary of Prof. Boris Dmitrievich Dobychin].
    VYSOTSKAIA KP
    Vestn Khir Im I I Grek; 1959 Apr; 82(4):156-7. PubMed ID: 13647911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Life and activities of Prof. Boris Aleksandrovich Chernogubov].
    Klin Med (Mosk); 1958 May; 36(5):156-7. PubMed ID: 13550701
    [No Abstract]   [Full Text] [Related]  

  • 7. [In memory of Prof. Boris Stepanovich Khominskii].
    Zh Vopr Neirokhir Im N N Burdenko; 1978; (3):61-2. PubMed ID: 354295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prof. Boris Vasil'evich Kliucharev (on his 70th birthday)].
    Vopr Onkol; 1976; 22(3):122. PubMed ID: 779261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prof. Boris Vladimirovich Verkhovskiĭ (on the 125th anniversary of his birth)].
    Shevrygin BV; Mchedlidze TP
    Feldsher Akush; 1988 Jun; 53(6):55-6. PubMed ID: 3044840
    [No Abstract]   [Full Text] [Related]  

  • 10. [In the memory of Prof. Dr. Boris Rajewsky].
    Pohlit W
    Biomed Tech (Berl); 1975 Feb; 20(1):39-40. PubMed ID: 1090309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prof. Boris Antonovich Teokharov (on his 70th birthday)].
    Vestn Dermatol Venerol; 1976 Sep; (9):92. PubMed ID: 799443
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Boris Rajewsky Prize for Prof. Dr. H. Muth].
    Zentralbl Arbeitsmed; 1974 Mar; 24(3):85. PubMed ID: 4599869
    [No Abstract]   [Full Text] [Related]  

  • 13. BORIS/CTCFL is an RNA-binding protein that associates with polysomes.
    Ogunkolade BW; Jones TA; Aarum J; Szary J; Owen N; Ottaviani D; Mumin MA; Patel S; Pieri CA; Silver AR; Sheer D
    BMC Cell Biol; 2013 Nov; 14():52. PubMed ID: 24279897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atractyloside mimics
    Fang M; Song Y; Ren J; Yuan H; Fang J; Yan D; Zhang Y; Wang X
    Int J Clin Exp Pathol; 2018; 11(7):3286-3293. PubMed ID: 31949703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer.
    Zhang Y; Song Y; Li C; Ren J; Fang M; Fang J; Wang X
    Oncol Lett; 2020 Nov; 20(5):251. PubMed ID: 32994814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
    Dougherty CJ; Ichim TE; Liu L; Reznik G; Min WP; Ghochikyan A; Agadjanyan MG; Reznik BN
    Biochem Biophys Res Commun; 2008 May; 370(1):109-12. PubMed ID: 18355444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.
    Zhang Y; Fang M; Li S; Xu H; Ren J; Tu L; Zuo B; Yao W; Liang G
    Mol Cancer; 2022 Aug; 21(1):158. PubMed ID: 35918747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastoma.
    Rao GK; Makani VKK; Mendonza JJ; Edathara PM; Patel N; Ramakrishna M; Cilamkoti P; Chiring Phukon J; Jose J; Bhadra U; Bhadra MP
    FEBS J; 2022 May; 289(10):2915-2934. PubMed ID: 34854238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    Horibe R; Hirohashi Y; Asano T; Mariya T; Suzuki T; Takaya A; Saijo H; Shionoya Y; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Watanabe K; Atsuyama E; Toji S; Hirano H; Hasegawa T; Takahashi H; Sato N; Torigoe T
    PLoS One; 2017; 12(3):e0171460. PubMed ID: 28248963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer.
    Zhang Y; Fang M; Song Y; Ren J; Fang J; Wang X
    Sci Rep; 2017 Jan; 7():40786. PubMed ID: 28098226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.